ArticleCureus2025
Rapidly Progressive Coexistence of Gastric Antral Vascular Ectasia (GAVE) and Portal Hypertensive Gastropathy (PHG) Presenting With Iron Deficiency Anaemia: Successful Use of PuraStat in a Patient With Implantable Cardioverter-Defibrillator (ICD).
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Advances in the diagnosis and treatment of portal hypertensive gastrointestinal and bile duct disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric antral vascular ectasia (GAVE), or "watermelon stomach", is an uncommon but important cause of chronic gastrointestinal blood loss and iron deficiency anaemia (IDA). Although associated with cirrhosis and portal hypertension, it is regarded as distinct from portal hypertensive gastropathy (PHG), and the two conditions rarely coexist. We report an 85-year-old woman with cirrhosis and multiple comorbidities who presented with severe symptomatic IDA (Hb 60 g/L). Remarkably, oesophago-gastro-duodenoscopy (OGD) performed just five months earlier had been entirely normal, yet repeat gastroscopy revealed rapidly developed GAVE and PHG with active bleeding. Endoscopic images demonstrated both GAVE and coexistent PHG, an uncommon finding. Haemostasis was achieved with PuraStat, chosen instead of argon plasma coagulation (APC) due to the presence of an implantable cardioverter-defibrillator (ICD). The patient required a blood transfusion and intravenous iron therapy, was stabilised clinically, and was discharged with structured follow-up. This case highlights the rapid evolution of GAVE, its potential to cause severe anaemia, the unusual coexistence of GAVE and PHG, and the successful use of PuraStat as a novel haemostatic option when APC is contraindicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.